Posts Tagged ‘Says’

fatnews.com Hi, this is Larry Hobbs @ FatNews.com. The diet drug Meridia (sibutramine) increases the risk of heart attack, stroke and cardiac arrest in older people with a history of heart disease or Type 2 diabetes according to information released from the US Food and Drug Administration on November 20th, 2009. Hi, this is Larry Hobbs @ FatNews.com. LarryHobbs@FatNews.com fatnews.com In a study of 10000 patients over the last 7 years (since 2002), more people given Meridia had a heart attack, stroke or cardiac arrest than those given a placebo. Cardiovascular events occurred in 11.4% of patients given Meridia versus 10% of those given a placebo. This difference is higher than expected, suggesting that sibutramine is associated with an increased cardiovascular risk in the study population. the FDA noted. Patients included in the study were 55 years of age or older, overweight or obese, and had a history of heart disease or type 2 diabetes plus one additional cardiovascular risk factor. The preliminary study findings highlight the importance of avoiding the use of sibutramine in patients with a history of coronary artery disease (heart disease), congestive heart failure (CHF), arrhythmias, or stroke…

(AFX UK Focus) 2010-06-26 16:55 Roche says diabetes drug studies show good results
ZURICH, June 26 (Reuters) – Swiss drugmaker Roche’s experimental diabetes drug taspoglutide showed good results in a series of late-stage studies, the group said on Saturday, after the drug suffered a severe setback just recently. Roche launched a risk mitigation programme for the drug developed under license from French group Ipsen after hypersensitivity problems were seen in some patients …

ACCORD Lipid Study brings new hope to people with type 2 diabetes and atherogenic dyslipidemia says international …
Cardiovascular risk can be reduced by an additional 31 percent in type 2 diabetes patients with atherogenic dyslipidemia, the common combination of elevated triglycerides (TG, 204 mg/dL or 2.3 mmol/L

Eye Condition Linked To Weakened Brain Power In People With Diabetes, Says New Research
Diabetic retinopathy could be associated with poorer memory and diminished brain power in people with Type 2 diabetes, according to new research announced this week at Diabetes UK’s Annual Professional Conference. The study looked at 1,066 people with Type 2 diabetes aged between 60 and 75 years. Participants completed seven tests looking at memory, logic and concentration to establish their …